Connecting for innovation and impact for all in global health
Join the African Forum for Research and Education in Health (AFREhealth) for its 8th Annual Conference under the theme “Reimagining Public Health in a Globalized World.” The conference will gather health professionals, researchers, educators, and policymakers from...
At a recent Clinton Global Initiative (CGI) Deeper Dive Session, PATH — together with Pfizer, the Bay Area Global Health Alliance, and Social Finance International — shared early-phase research findings aimed at understanding the drivers of antibiotic misuse and presented an innovative financing design approach to incentivize the correct use of antibiotics. The session aimed to raise awareness and engage potential partners around a next-phase pilot to test outcomes-based financing (OBF) as a new tool to drive more sustainable and effective stewardship.
On February 25, Neha Agarwal, senior director of strategy at PATH and Alliance board vice chair, led a session for Stanford Mussallem Center for Biodesign’s Innovation and Health Equity Series. She discussed how outcomes-based financing (OBF) can be leveraged to tackle antimicrobial resistance (AMR). Her talk, which provided a first look at data from a year-long study in Tanzania and Senegal, emphasized how innovative financing mechanisms could reshape global health strategies.
During the Clinton Global Initiative (CGI) 2024 Annual Meeting, PATH, in partnership with the Bay Area Global Health Alliance and Pfizer, announced a Commitment to Action: Outcomes-Based Financing as a Tool to Curb AMR in LMICs. This commitment aims to combat antimicrobial resistance (AMR) and incentivize antimicrobial stewardship (AMS) through an innovative outcomes-based financing mechanism.
PATH Read More
Join Alliance member PATH for the opportunity to review key findings and learnings from the Tools for Integrated Management of Childhood Illness (TIMCI) project. Tools like Pulse Oximeters empower health workers to identify critically ill children and refer them for treatment without delay. TIMCI is a Unitaid-funded initiative led by PATH, in partnership with the Swiss Tropical and Public Health Institute and local research partners in India (Uttar Pradesh), Kenya, Senegal, and Tanzania. Between 2019 and 2024, the TIMCI project worked in collaboration with the country governments to improve access to affordable and appropriate tools to help health care providers identify and manage children who are severely ill.